Amit Garg, MD, FAAD

Associate Professor, Center for Health Innovations and Outcomes Research,
The Feinstein Institute for Medical Research

Professor & Founding Chairman, Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Phone: (516) 321-8541

About the Investigator

Dr. Garg is Professor and Founding Chairman for the Department of Dermatology at the Zucker School of Medicine at Hofstra/Northwell. He also serves as the Senior Vice President of the Dermatology Service Line at Northwell Health. He has held full-time faculty positions at the University of Massachusetts Medical School and at the Boston University School of Medicine, where he directed the Residency Training Program in Dermatology.

Dr. Garg’s subspecialty expertise is interdisciplinary based in caring for patients with autoimmune and inflammatory conditions including hidradenitis suppurativa, psoriasis, lupus, and dermatomyositis.

Dr. Garg has held leadership roles within national professional organizations, including the American Academy of Dermatology, the American Board of Dermatology, the Association of Professors of Dermatology, the Medical Dermatological Society, the National Psoriasis Foundation, the Hidradenitis Suppurativa Foundation, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and the International Dermatology Outcome Measures group. He is a member of Dermatology’s Residency Review Committee of Accreditation Counsel of Graduate Medical Education.

Dr. Garg has served on editorial boards for journals as well as American Academy of Dermatology based publications. He has published a number of articles in the peer-reviewed literature and has authored several book chapters. Dr. Garg was awarded the 2016 Thomas G. Pearson, EdD Memorial Education Award by the American Academy of Dermatology.

Research Focus

Dr. Garg’s funded research interests include developing measurement instruments and assessing clinical and patient centered outcomes in psoriasis and hidradenitis suppurativa. Through his grants, Dr. Garg has also developed innovative teaching strategies to improve training and education outcomes. His past research focused on improving teaching and assessment methods in undergraduate and graduate medical education, as well as narrowing the practice gaps related to the skin cancer examination through increasing awareness of high risk patient groups, promoting integration of the skin cancer exam into the routine or focused physical exam, and enabling detection of suspicious pigmented lesions.


Tufts University, Medford, MA
Degree: BA
Field of Study: Biology and Spanish, Magna Cum Laude

University of Massachusetts Medical School, Boston, MA
Degree: MD
Field of Study: Medicine

University of Illinois at Chicago
Degree: Intern
Field of Study: Preliminary Medicine

University of Illinois at Chicago
Degree: Resident, Chief Resident
Field of Study: Dermatology

Awards & Honors
2016 Recipient, Thomas G. Pearson, EdD Memorial Education Award, American Academy of Dermatology


  1. Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N. Prevalence Estimates For Hidradenitis Suppurativa Among Children and Adolescents in the United States: a gender and age adjusted population analysis. J Invest Dermatol. Status: accepted for publication.
  2. Garg A, Hundal J, Strunk A. Overall and Subgroup Prevalence of Crohn’s Disease Among Patients with Hidradenitis Suppurativa: a population based analysis in the United States. JAMA Dermatol. Status: accepted for publication.
  3. Garg A, Papagermanos V, Midura M, Strunk A, Merson J. Opioid, Alcohol, and Cannabis Misuse Among Patients with Hidradenitis Suppurativa: a population analysis in the United States. J Am Acad Dermatol. doi: 10.1016/j.jaad.2018.02.053
  4. Garg A, Slyper M, Strunk A. Incidence of Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: a population based retrospective analysis. Br J Dermatol. 2018 Feb 25. doi: 10.1111/bjd.16483
  5. Garg A, Birabaharan M, Strunk A. Prevalence of Type II Diabetes Mellitus Among Patients with Hidradenitis Suppurativa in the United States. J Am Acad Dermatol. 2018 Jan 12. pii: S0190-9622(18)30098-7. doi: 10.1016/j.jaad.2018.01.014
  6. Garg A, Neuren E, Strunk A. Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States. J Invest Dermatol. 2018 Feb 19. pii: S0022-202X(18)30027-7. doi: 10.1016/j.jid.2018.01.009
  7. Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A (co-senior author), Jemec GBE, on behalf of the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC). A Core Domain Set For Hidradenitis Suppurativa Trial Outcomes: An International Delphi Process. Br J Dermatol. Status: Accepted for publication.
  8. Thorlacius L, Garg A (co-first author), Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernandez-Penas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens E, Randel S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Towards global consensus on core outcomes for Hidradenitis Suppurativa research: An update from the HISTORIC consensus meetings I and II. Br J Dermatol. 2018;178(3):715-721.
  9. Garg A, Strunk A, Midura M, Papagermanos V, Pomerantz H. Prevalence of Hidradenitis Suppurativa Among Patients with Down Syndrome: a population based cross sectional analysis. Br J Dermatol. 2018;178(3):697-703
  10. Garg A, Papagermanos V, Midura M, Strunk A. Incidence of Hidradenitis Suppurativa among Tobacco Smokers: a population based retrospective analysis in the United States. Br J Dermatol. 2018;178(3):709-714.

View more at PubMed